Denali Therapeutics outlines 2026 milestones including Hunter syndrome launch
Go back to Denali Therapeutics outlines 2026 milestones including Hunter syndrome launch| (NASDAQ: DNLI) | Delayed: 22.65 -0.61 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.26 | 52 Week High | $ | |||
| Open | $23.33 | 52 Week Low | $ | |||
| Day High | $23.86 | P/E | N/A | |||
| Day Low | $22.53 | EPS | $ | |||
| Volume | 966,692 | |||||

